| Dr Ramanpal Singh Grewal, DDS | |
|
3507 Tully Rd Ste 50, Modesto, CA 95356-1000 | |
| (209) 408-8069 | |
| (209) 409-8299 |
| Full Name | Dr Ramanpal Singh Grewal |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 3507 Tully Rd Ste 50, Modesto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295984128 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 57358 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ramanpal Singh Grewal, DDS 3507 Tully Rd Ste 50, Modesto, CA 95356-1000 Ph: (209) 408-8069 | Dr Ramanpal Singh Grewal, DDS 3507 Tully Rd Ste 50, Modesto, CA 95356-1000 Ph: (209) 408-8069 |
News Archive
Rice University engineers are building a flat microscope, called FlatScope TM, and developing software that can decode and trigger neurons on the surface of the brain.
An experimental drug improves the ability of heart muscle cells damaged by heart failure to pump blood, according to the results of a study led by Icahn School of Medicine at Mount Sinai researchers and published online today in Nature Communications.
Academic and Community Cancer Research United (ACCRU) today announced the opening of a two-arm, randomized phase III, FDA registration trial of eribulin compared to standard weekly paclitaxel as first- or second-line chemotherapy for individuals with human epidermal growth factor receptor 2 (HER2) negative, locally recurrent, unresectable or metastatic breast cancer.
Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.
Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of OBI-1, a recombinant antihemophilic porcine sequence factor VIII, in patients with acquired hemophilia A.
› Verified 3 days ago
Bhavini Harish Shelat, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2801 Coffee Rd, Building B, Modesto, CA 95355 Phone: 209-727-4296 | |
Dr. Martha L Gomez, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 1130 Coffee Rd, Suite 9a, Modesto, CA 95355 Phone: 209-522-8783 Fax: 209-526-1470 | |
Saliem Melles Tsighe, D.M.D Dentist Medicare: Medicare Enrolled Practice Location: 2200 Mchenry Ave Ste B, Modesto, CA 95350 Phone: 209-526-9132 | |
Dr. John R Jeppson, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1429 College Ave, Suite G, Modesto, CA 95350 Phone: 209-526-0344 Fax: 209-526-0370 | |
Dr. Samuel Ernest Bleakley, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1601 Mchenry Village Way Ste 1, Modesto, CA 95350 Phone: 209-577-1313 Fax: 209-577-8584 | |
Efraim Sanson Florendo, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2605 Coffee Rd, Modesto, CA 95055 Phone: 209-521-0100 | |
Lynn Zwahlen, DDS Dentist Medicare: Medicare Enrolled Practice Location: 201 E Orangeburg Ave Ste C, Modesto, CA 95350 Phone: 209-522-5761 Fax: 209-522-1051 |